Abstract
HIV-1 drug resistance represents a major obstacle to infection and disease control. This retrospective study analyzes trends and determinants of resistance in antiretroviral treatment (ART)-exposed individuals across 7 countries in Europe. Of 20 323 cases, 80% carried at least one resistance mutation: these declined from 81% in 1997 to 71% in 2008. Predicted extensive 3-class resistance was rare (3.2% considering the cumulative genotype) and peaked at 4.5% in 2005, decreasing thereafter. The proportion of cases exhausting available drug options dropped from 32% in 2000 to 1% in 2008. Reduced risk of resistance over calendar years was confirmed by multivariable analysis.
Original language | Undefined/Unknown |
---|---|
Pages (from-to) | 1216-1220 |
Number of pages | 5 |
Journal | Journal of Infectious Diseases |
Volume | 207 |
Issue number | 8 |
DOIs | |
Publication status | Published - 2013 |
Research programs
- EMC MM-04-27-01